{"id":"https://openalex.org/W1998236274","doi":"https://doi.org/10.1038/jid.2011.37","title":"cis-Urocanic Acid Enhances Prostaglandin E2 Release and Apoptotic Cell Death via Reactive Oxygen Species in Human Keratinocytes","display_name":"cis-Urocanic Acid Enhances Prostaglandin E2 Release and Apoptotic Cell Death via Reactive Oxygen Species in Human Keratinocytes","publication_year":2011,"publication_date":"2011-03-17","ids":{"openalex":"https://openalex.org/W1998236274","doi":"https://doi.org/10.1038/jid.2011.37","mag":"1998236274","pmid":"https://pubmed.ncbi.nlm.nih.gov/21412256"},"language":"en","primary_location":{"id":"doi:10.1038/jid.2011.37","doi":"https://doi.org/10.1038/jid.2011.37","is_oa":true,"landing_page_url":"https://doi.org/10.1038/jid.2011.37","pdf_url":null,"source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1038/jid.2011.37","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024285087","display_name":"Kazuyo Kaneko","orcid":"https://orcid.org/0000-0001-8644-2341","observed_orcids":["https://orcid.org/0000-0001-8644-2341"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kazuyo Kaneko","raw_affiliation_strings":["St. John's Institute of Dermatology, King's College London School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's Institute of Dermatology, King's College London School of Medicine, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091482514","display_name":"Susan L. Walker","orcid":"https://orcid.org/0000-0003-3187-5195","observed_orcids":["https://orcid.org/0000-0003-3187-5195"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Susan L. Walker","raw_affiliation_strings":["St. John's Institute of Dermatology, King's College London School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's Institute of Dermatology, King's College London School of Medicine, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114254746","display_name":"Joey E. Lai\u2010Cheong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joey Lai-Cheong","raw_affiliation_strings":["St. John's Institute of Dermatology, King's College London School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's Institute of Dermatology, King's College London School of Medicine, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077865685","display_name":"Mary Steidl Matsui","orcid":"https://orcid.org/0000-0002-0071-4658","observed_orcids":["https://orcid.org/0000-0002-0071-4658"]},"institutions":[{"id":"https://openalex.org/I4210126082","display_name":"Est\u00e9e Lauder (United States)","ror":"https://ror.org/0411v1p84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126082"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary S. Matsui","raw_affiliation_strings":["The Estee Lauder Companies, Melville, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Estee Lauder Companies, Melville, New York, USA","institution_ids":["https://openalex.org/I4210126082"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105369643","display_name":"Mary Norval","orcid":"https://orcid.org/0000-0003-4940-0403","observed_orcids":["https://orcid.org/0000-0003-4940-0403"]},"institutions":[{"id":"https://openalex.org/I98677209","display_name":"University of Edinburgh","ror":"https://ror.org/01nrxwf90","country_code":"GB","type":"education","lineage":["https://openalex.org/I98677209"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mary Norval","raw_affiliation_strings":["Biomedical Sciences, University of Edinburgh Medical School, Edinburgh, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Sciences, University of Edinburgh Medical School, Edinburgh, UK","institution_ids":["https://openalex.org/I98677209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064410212","display_name":"Antony Richard Young","orcid":"https://orcid.org/0000-0002-4163-6772","observed_orcids":["https://orcid.org/0000-0002-4163-6772"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Antony R. Young","raw_affiliation_strings":["St. John's Institute of Dermatology, King's College London School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's Institute of Dermatology, King's College London School of Medicine, London, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5064410212"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":2.0189,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.84284167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"131","issue":"6","first_page":"1262","last_page":"1271"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cis-urocanic-acid","display_name":"cis-urocanic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/trans-urocanic-acid","display_name":"trans-urocanic acid","score":0.906000018119812},{"id":"https://openalex.org/keywords/photoisomerization","display_name":"photoisomerization","score":0.8009999990463257},{"id":"https://openalex.org/keywords/ultraviolet-radiation","display_name":"ultraviolet radiation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/human-keratinocytes","display_name":"human keratinocytes","score":0.7889999747276306},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.8650000095367432},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9800000190734863},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8790000081062317},{"id":"https://openalex.org/keywords/egfr-signaling","display_name":"EGFR signaling","score":0.8859999775886536},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.6819999814033508},{"id":"https://openalex.org/keywords/erk","display_name":"ERK","score":0.9670000076293945},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9940000176429749},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9380000233650208},{"id":"https://openalex.org/keywords/alpha-tocopherol","display_name":"alpha-tocopherol","score":0.9269999861717224},{"id":"https://openalex.org/keywords/antioxidants","display_name":"antioxidants","score":0.4099999964237213},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.6550154089927673},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5937622785568237},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5874358415603638},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.53622967004776},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.49746325612068176},{"id":"https://openalex.org/C51551487","wikidata":"https://www.wikidata.org/wiki/Q2043632","display_name":"p38 mitogen-activated protein kinases","level":4,"score":0.4802291989326477},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.467311829328537},{"id":"https://openalex.org/C2777074287","wikidata":"https://www.wikidata.org/wiki/Q1473931","display_name":"Keratinocyte","level":3,"score":0.45558059215545654},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4416584372520447},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4389791786670685},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.4122239351272583},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38052603602409363},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2607969045639038},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014560","descriptor_name":"Urocanic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015232","descriptor_name":"Dinoprostone","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015603","descriptor_name":"Keratinocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D048049","descriptor_name":"Extracellular Signal-Regulated MAP Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D048051","descriptor_name":"p38 Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/jid.2011.37","doi":"https://doi.org/10.1038/jid.2011.37","is_oa":true,"landing_page_url":"https://doi.org/10.1038/jid.2011.37","pdf_url":null,"source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},{"id":"pmid:21412256","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21412256","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of investigative dermatology","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/7e242ad3-ae1d-47e5-b557-beb4cf216a34","doi":null,"is_oa":false,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/7e242ad3-ae1d-47e5-b557-beb4cf216a34","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Kaneko, K, Walker, S L, Lai-Cheong, J, Matsui, M S, Norval, M & Young, A R 2011, 'cis-Urocanic Acid Enhances Prostaglandin E-2 Release and Apoptotic Cell Death via Reactive Oxygen Species in Human Keratinocytes', Journal of Investigative Dermatology, vol. 131, no. 6, pp. 1262 - 1271. https://doi.org/10.1038/jid.2011.37","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/jid.2011.37","doi":"https://doi.org/10.1038/jid.2011.37","is_oa":true,"landing_page_url":"https://doi.org/10.1038/jid.2011.37","pdf_url":null,"source":{"id":"https://openalex.org/S28607811","display_name":"Journal of Investigative Dermatology","issn_l":"0022-202X","issn":["0022-202X","1523-1747"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W1487702980","https://openalex.org/W1514311943","https://openalex.org/W1808321390","https://openalex.org/W1944006756","https://openalex.org/W1954540631","https://openalex.org/W1968529156","https://openalex.org/W1969118462","https://openalex.org/W1972692044","https://openalex.org/W1982715515","https://openalex.org/W1984350665","https://openalex.org/W1988357714","https://openalex.org/W1989280230","https://openalex.org/W1990815184","https://openalex.org/W1998267570","https://openalex.org/W1999605572","https://openalex.org/W1999723636","https://openalex.org/W2002927316","https://openalex.org/W2008983628","https://openalex.org/W2011344575","https://openalex.org/W2012579173","https://openalex.org/W2017908931","https://openalex.org/W2018612646","https://openalex.org/W2020261641","https://openalex.org/W2021122120","https://openalex.org/W2027765261","https://openalex.org/W2028044960","https://openalex.org/W2037753878","https://openalex.org/W2044485209","https://openalex.org/W2048143381","https://openalex.org/W2051719153","https://openalex.org/W2057308886","https://openalex.org/W2062076105","https://openalex.org/W2066589243","https://openalex.org/W2070386351","https://openalex.org/W2074361322","https://openalex.org/W2075917248","https://openalex.org/W2078682475","https://openalex.org/W2083947040","https://openalex.org/W2090944139","https://openalex.org/W2091764628","https://openalex.org/W2093522919","https://openalex.org/W2100081779","https://openalex.org/W2109624037","https://openalex.org/W2111986039","https://openalex.org/W2117140314","https://openalex.org/W2119133130","https://openalex.org/W2124012982","https://openalex.org/W2125169413","https://openalex.org/W2142847551","https://openalex.org/W2147320629","https://openalex.org/W2147577387","https://openalex.org/W2149632564","https://openalex.org/W2156272519","https://openalex.org/W2158018425"],"related_works":["https://openalex.org/W2610418318","https://openalex.org/W2091764628","https://openalex.org/W1892101554","https://openalex.org/W2062076105","https://openalex.org/W2024664492","https://openalex.org/W1512774594","https://openalex.org/W1996048204","https://openalex.org/W2030452265","https://openalex.org/W2085629375","https://openalex.org/W2066589243"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}